FM talks the market up, but is it a booster dose or a placebo?

FM talks the market up, but is it a booster dose or a placebo? At 19X FY20e earnings, markets are not cheap. With earnings likely to remain elusive, the short-lived rally over FM’s announcement is likely to give way to a long-period of consolidation with a hawk eye on cues for decisive revival.

No comments:

Post a Comment